Tapewire

Nasdaq · USD

ALLO

Allogene Therapeutics, Inc.

Export transactions ↓
Tapewire entity
5243
SEC CIK
0001737287
Parsed reports
274

Last 12 months

Inside the activity.

0 purchase rows · 14 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202601
Feb 202606
Mar 202604
Apr 202601
May 202600
Jun 202600
Jul 202600
Aug 202601
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 21, 2025 Filed Apr 23, 2025 21:28 UTC
Yoshiyama AnnieSVP, Finance
SaleCommon Stock 9,601 $1.41 $13,537.41
Disclosure

SEC source: 0001835208-25-000007 · wk-form4_1745443726.xml · nonDerivative · entry 1

Yoshiyama Annie · CIK 0001835208 · SVP, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,663

F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Includes 2274 shares of the Issuer's common stock acquired by the reporting person on March 14, 2025 pursuant to an employee stock purchase program.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 21:28 UTC
Beneski Benjamin MachinasSVP, Chief Technical Officer
SaleCommon Stock 5,488 $1.98 $10,838.80
Disclosure

SEC source: 0001737287-25-000040 · wk-form4_1742333277.xml · nonDerivative · entry 1

Beneski Benjamin Machinas · CIK 0002057918 · SVP, Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 218,507

F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in one transaction at the single price point of $1.975. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at the price set forth above.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 21:30 UTC
Chang David DDirector · President and CEO
SaleCommon Stock 46,668 $1.96 $91,469.28
Disclosure

SEC source: 0001737287-25-000042 · wk-form4_1742333443.xml · nonDerivative · entry 1

Chang David D · CIK 0001611024 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,276,569

F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in one transaction at a single price point of $1.96. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at the price set forth above.

F3 · balance_after: Includes 6000 shares of the Issuer's common stock acquired by the reporting person on March 14, 2025 pursuant to an employee stock purchase program.

Read SEC document
March 01, 2025 Filed Mar 5, 2025 21:11 UTC
Beneski Benjamin MachinasSVP, Chief Technical Officer
GrantStock Option (Right to buy) · Derivative 112,339 $0.00 Strike: $1.80 $0.00
Disclosure

SEC source: 0001737287-25-000026 · wk-form4_1741209067.xml · derivative · entry 2

Beneski Benjamin Machinas · CIK 0002057918 · SVP, Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,339

Underlying: Common Stock · 112,339 shares

Expires 2035-03-01

F1 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest on March 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter.

Read SEC document
March 01, 2025 Filed Mar 5, 2025 21:11 UTC
Beneski Benjamin MachinasSVP, Chief Technical Officer
GrantCommon Stock 31,755 $0.00 $0.00
Disclosure

SEC source: 0001737287-25-000026 · wk-form4_1741209067.xml · nonDerivative · entry 1

Beneski Benjamin Machinas · CIK 0002057918 · SVP, Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 223,995

Read SEC document
February 18, 2025 Filed Feb 20, 2025 21:15 UTC SaleCommon Stock 13,313 $2.43 $32,350.59
Disclosure

SEC source: 0001737287-25-000022 · wk-form4_1740086122.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 144,316

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/30/2024.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $2.42 to $2.44, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 21:12 UTC
Roberts ZacharyEVP of R&D
SaleCommon Stock 18,832 $1.70 $32,014.40
Disclosure

SEC source: 0001737287-25-000016 · wk-form4_1738789969.xml · nonDerivative · entry 1

Roberts Zachary · CIK 0001851044 · EVP of R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 643,135

F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 16:14 UTC
MOORE TIMOTHY L.Chief Technical Officer
SaleCommon Stock 14,746 $1.71 $25,215.66
Disclosure

SEC source: 0001737287-25-000018 · wk-form4_1738790068.xml · nonDerivative · entry 1

MOORE TIMOTHY L. · CIK 0001669207 · Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,713

F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.71 to $1.715, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with in the rage set forth above.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 21:15 UTC
Parker Geoffrey M.CHIEF FINANCIAL OFFICER
SaleCommon Stock 4,361 $1.73 $7,544.53
Disclosure

SEC source: 0001737287-25-000019 · wk-form4_1738790139.xml · nonDerivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,301,540

F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 21:16 UTC
Douglas Earl MartinSVP, General Counsel
SaleCommon Stock 6,404 $1.71 $10,950.84
Disclosure

SEC source: 0001737287-25-000020 · wk-form4_1738790190.xml · nonDerivative · entry 1

Douglas Earl Martin · CIK 0001362155 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 587,848

F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 21:13 UTC
Chang David DDirector · President and CEO
SaleCommon Stock 46,003 $1.68 $77,285.04
Disclosure

SEC source: 0001737287-25-000017 · wk-form4_1738790016.xml · nonDerivative · entry 1

Chang David D · CIK 0001611024 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,317,237

F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.68 to $1.69, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with in the rage set forth above.

Read SEC document
January 24, 2025 Filed Jan 29, 2025 01:13 UTC
Roberts ZacharyEVP of R&D
GrantStock Option (Right to buy) · Derivative 614,844 $0.00 Strike: $1.94 $0.00
Disclosure

SEC source: 0001737287-25-000006 · wk-form4_1738113175.xml · derivative · entry 2

Roberts Zachary · CIK 0001851044 · EVP of R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 614,844

Underlying: Common Stock · 614,844 shares

Expires 2035-01-24

F1 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest on January 24, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter.

Read SEC document
January 24, 2025 Filed Jan 29, 2025 01:13 UTC
Roberts ZacharyEVP of R&D
GrantCommon Stock 173,913 $0.00 $0.00
Disclosure

SEC source: 0001737287-25-000006 · wk-form4_1738113175.xml · nonDerivative · entry 1

Roberts Zachary · CIK 0001851044 · EVP of R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 661,967

Read SEC document
January 24, 2025 Filed Jan 29, 2025 01:15 UTC
Parker Geoffrey M.CHIEF FINANCIAL OFFICER
GrantStock Option (Right to buy) · Derivative 614,844 $0.00 Strike: $1.94 $0.00
Disclosure

SEC source: 0001737287-25-000008 · wk-form4_1738113304.xml · derivative · entry 2

Parker Geoffrey M. · CIK 0001491874 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 614,844

Underlying: Common Stock · 614,844 shares

Expires 2035-01-24

F1 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest on January 24, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter.

Read SEC document
January 24, 2025 Filed Jan 29, 2025 01:15 UTC
Parker Geoffrey M.CHIEF FINANCIAL OFFICER
GrantCommon Stock 173,913 $0.00 $0.00
Disclosure

SEC source: 0001737287-25-000008 · wk-form4_1738113304.xml · nonDerivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,305,901

Read SEC document
January 24, 2025 Filed Jan 29, 2025 01:11 UTC GrantStock Option (Right to buy) · Derivative 1,307,927 $0.00 Strike: $1.94 $0.00
Disclosure

SEC source: 0001737287-25-000005 · wk-form4_1738113099.xml · derivative · entry 6

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,307,927

Underlying: Common Stock · 1,307,927 shares

Expires 2035-01-24

F5 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest on January 24, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter.

Read SEC document
January 24, 2025 Filed Jan 29, 2025 01:11 UTC GrantCommon Stock 369,957 $0.00 $0.00
Disclosure

SEC source: 0001737287-25-000005 · wk-form4_1738113099.xml · nonDerivative · entry 1

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,236,816

Read SEC document
January 24, 2025 Filed Jan 29, 2025 01:16 UTC
Douglas Earl MartinSVP, General Counsel
GrantStock Option (Right to buy) · Derivative 512,370 $0.00 Strike: $1.94 $0.00
Disclosure

SEC source: 0001737287-25-000009 · wk-form4_1738113364.xml · derivative · entry 2

Douglas Earl Martin · CIK 0001362155 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 512,370

Underlying: Common Stock · 512,370 shares

Expires 2035-01-24

F1 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest on January 24, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter.

Read SEC document
January 24, 2025 Filed Jan 29, 2025 01:16 UTC
Douglas Earl MartinSVP, General Counsel
GrantCommon Stock 144,928 $0.00 $0.00
Disclosure

SEC source: 0001737287-25-000009 · wk-form4_1738113364.xml · nonDerivative · entry 1

Douglas Earl Martin · CIK 0001362155 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 594,252

Read SEC document
January 24, 2025 Filed Jan 29, 2025 01:10 UTC
Chang David DDirector · President and CEO
GrantStock Option (Right to buy) · Derivative 1,952,130 $0.00 Strike: $1.94 $0.00
Disclosure

SEC source: 0001737287-25-000004 · wk-form4_1738113042.xml · derivative · entry 5

Chang David D · CIK 0001611024 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,952,130

Underlying: Common Stock · 1,952,130 shares

Expires 2035-01-24

F5 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest on January 24, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter.

Read SEC document
January 24, 2025 Filed Jan 29, 2025 01:10 UTC
Chang David DDirector · President and CEO
GrantCommon Stock 552,174 $0.00 $0.00
Disclosure

SEC source: 0001737287-25-000004 · wk-form4_1738113042.xml · nonDerivative · entry 1

Chang David D · CIK 0001611024 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,363,240

F1 · balance_after: Includes 960 shares of the Issuer's common stock acquired by the reporting person on September 15, 2024 pursuant to an employee stock purchase program.

Read SEC document
January 24, 2025 Filed Jan 29, 2025 01:14 UTC
Yoshiyama AnnieSVP, Finance
GrantStock Option (Right to buy) · Derivative 128,093 $0.00 Strike: $1.94 $0.00
Disclosure

SEC source: 0001737287-25-000007 · wk-form4_1738113240.xml · derivative · entry 2

Yoshiyama Annie · CIK 0001835208 · SVP, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 128,093

Underlying: Common Stock · 128,093 shares

Expires 2035-01-24

F1 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest on January 24, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter.

Read SEC document
January 24, 2025 Filed Jan 29, 2025 01:14 UTC
Yoshiyama AnnieSVP, Finance
GrantCommon Stock 36,232 $0.00 $0.00
Disclosure

SEC source: 0001737287-25-000007 · wk-form4_1738113240.xml · nonDerivative · entry 1

Yoshiyama Annie · CIK 0001835208 · SVP, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 137,990

Read SEC document
January 21, 2025 Filed Jan 23, 2025 21:30 UTC
Roberts ZacharyEVP of R&D
SaleCommon Stock 27,199 $1.78 $48,414.22
Disclosure

SEC source: 0001737287-25-000003 · wk-form4_1737667821.xml · nonDerivative · entry 1

Roberts Zachary · CIK 0001851044 · EVP of R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 488,054

F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.78 to $1.805, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with in the rage set forth above.

Read SEC document
December 09, 2024 Filed Dec 10, 2024 21:53 UTC SaleCommon Stock 9,136 $2.18 $19,916.48
Disclosure

SEC source: 0001737287-24-000081 · wk-form4_1733867628.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 157,629

F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices raging from $2.16 to $2.21, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
December 05, 2024 Filed Dec 9, 2024 21:05 UTC SaleCommon Stock 9,221 $2.16 $19,917.36
Disclosure

SEC source: 0001737287-24-000079 · wk-form4_1733778343.xml · nonDerivative · entry 1

Humer Franz B · CIK 0001548072 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 307,507

F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices raging from $2.145 to $2.185, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
October 21, 2024 Filed Oct 23, 2024 20:21 UTC
Parker Geoffrey M.CHIEF FINANCIAL OFFICER
Tax withholdingCommon Stock 36,404 $2.84 $103,387.36
Disclosure

SEC source: 0001737287-24-000065 · wk-form4_1729714884.xml · nonDerivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,131,988

F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.82 to $2.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F3 · balance_after: Includes 3,974 shares of the Issuer's common stock acquired by the reporting person on September 15, 2024 pursuant to an employee stock purchase program.

Read SEC document
August 21, 2024 Filed Aug 23, 2024 20:15 UTC
Douglas Earl MartinSVP, General Counsel
Tax withholdingCommon Stock 28,310 $2.79 $78,843.35
Disclosure

SEC source: 0001593968-24-001096 · primary_01.xml · nonDerivative · entry 1

Douglas Earl Martin · CIK 0001362155 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 449,324

F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.75 to $2.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
June 18, 2024 Filed Jun 20, 2024 20:31 UTC SaleCommon Stock 18,641 $2.28 $42,488.43
Disclosure

SEC source: 0001593968-24-000878 · primary_01.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 166,765

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/29/2023

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.25 to $2.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 21:28 UTC GrantStock Option (Right to buy) · Derivative 191,082 $0.00 Strike: $2.44 $0.00
Disclosure

SEC source: 0001593968-24-000836 · primary_01.xml · derivative · entry 1

Kazam Joshua A · CIK 0001221355 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 191,082

Underlying: Common Stock · 191,082 shares

Expires 2034-06-05

F1 · derivative.exercise_date: Vesting in 12 equal monthly installments

Read SEC document
June 05, 2024 Filed Jun 7, 2024 21:33 UTC
SATO VICKI LDirector
GrantStock Option (Right to buy) · Derivative 95,541 $0.00 Strike: $2.44 $0.00
Disclosure

SEC source: 0001593968-24-000839 · primary_01.xml · derivative · entry 2

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,541

Underlying: Common Stock · 95,541 shares

Expires 2034-06-05

F1 · derivative.exercise_date: Vesting in 12 equal monthly installments

Read SEC document
June 05, 2024 Filed Jun 7, 2024 21:33 UTC
SATO VICKI LDirector
GrantCommon Stock 61,475 $0.00 $0.00
Disclosure

SEC source: 0001593968-24-000839 · primary_01.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 162,575

Read SEC document
June 05, 2024 Filed Jun 7, 2024 21:30 UTC GrantStock Option (Right to buy) · Derivative 95,541 $0.00 Strike: $2.44 $0.00
Disclosure

SEC source: 0001593968-24-000838 · primary_01.xml · derivative · entry 2

Humer Franz B · CIK 0001548072 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,541

Underlying: Common Stock · 95,541 shares

Expires 2034-06-05

F1 · derivative.exercise_date: Vesting in 12 equal monthly installments

Read SEC document
June 05, 2024 Filed Jun 7, 2024 21:30 UTC GrantCommon Stock 61,475 $0.00 $0.00
Disclosure

SEC source: 0001593968-24-000838 · primary_01.xml · nonDerivative · entry 1

Humer Franz B · CIK 0001548072 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 316,728

Read SEC document
June 05, 2024 Filed Jun 7, 2024 21:29 UTC GrantStock Option (Right to buy) · Derivative 191,082 $0.00 Strike: $2.44 $0.00
Disclosure

SEC source: 0001593968-24-000837 · primary_01.xml · derivative · entry 1

WITTE OWEN N. · CIK 0001700969 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 191,082

Underlying: Common Stock · 191,082 shares

Expires 2034-06-05

F1 · derivative.exercise_date: Vesting in 12 equal monthly installments

Read SEC document
June 05, 2024 Filed Jun 7, 2024 21:35 UTC
Mayo StephenDirector
GrantStock Option (Right to buy) · Derivative 191,082 $0.00 Strike: $2.44 $0.00
Disclosure

SEC source: 0001593968-24-000841 · primary_01.xml · derivative · entry 1

Mayo Stephen · CIK 0001849061 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 191,082

Underlying: Common Stock · 191,082 shares

Expires 2034-06-05

F1 · derivative.exercise_date: Vesting in 12 equal monthly installments

Read SEC document
June 05, 2024 Filed Jun 7, 2024 21:34 UTC GrantStock Option (Right to buy) · Derivative 191,082 $0.00 Strike: $2.44 $0.00
Disclosure

SEC source: 0001593968-24-000840 · primary_01.xml · derivative · entry 1

Barrett Elizabeth A. · CIK 0001764157 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 191,082

Underlying: Common Stock · 191,082 shares

Expires 2034-06-05

F1 · derivative.exercise_date: Vesting in 12 equal monthly installments

Read SEC document
June 05, 2024 Filed Jun 7, 2024 21:25 UTC GrantCommon Stock 122,950 $0.00 $0.00
Disclosure

SEC source: 0001593968-24-000835 · primary_01.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 185,406

Read SEC document
May 30, 2024 Filed Jun 3, 2024 20:09 UTC SaleCommon Stock 11,200 $2.34 $26,181.12
Disclosure

SEC source: 0001593968-24-000783 · primary_01.xml · nonDerivative · entry 1

Humer Franz B · CIK 0001548072 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 255,253

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.31 to $2.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
May 16, 2024 Filed May 20, 2024 22:02 UTC
Parker Geoffrey M.CHIEF FINANCIAL OFFICER
GrantCommon Stock 344,828 $2.90 $1,000,001.20
Disclosure

SEC source: 0001593968-24-000715 · primary_01.xml · nonDerivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,164,418

F1 · shares: These shares of common stock were acquired directly from Allogene Therapeutics, Inc (the "Issuer") in a registered direct offering.

Read SEC document
May 16, 2024 Filed May 21, 2024 01:33 UTC PurchaseCommon Stock 1,724,137 $2.90 $4,999,997.30
Disclosure

SEC source: 0001737287-24-000042 · primary_doc.xml · nonDerivative · entry 2

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,724,137

F3 · shares: Consists of 1,720,172 shares of common stock acquired by Vida Ventures III, L.P. and 3,965 shares of common stock acquired by Vida Ventures III A, L.P. from Goldman Sachs (the Underwriter) in a registered direct offering.

F4 · ownership.nature: The securities are held by Vida Ventures III, L.P. and Vida Ventures III-A, L.P. Vida Ventures GP III, LLC is the manager of Vida Ventures III, L.P. and Vida Ventures III-A, L.P. The reporting person is a Senior Managing Director of Vida Ventures GP III, LLC and may therefore be deemed to be the beneficial owner of the common shares held by Vida Ventures III, L.P. and Vida Ventures III-A, L.P. The reporting person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.

Read SEC document
May 16, 2024 Filed May 21, 2024 01:33 UTC GrantCommon Stock 344,828 $2.90 $1,000,001.20
Disclosure

SEC source: 0001737287-24-000042 · primary_doc.xml · nonDerivative · entry 1

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 539,867

F1 · shares: These shares of common stock were acquired directly from Allogene Therapeutics, Inc (the "Issuer") in a registered direct offering.

F2 · ownership.nature: The securities are held in the name of Bellco Legacy LLC. Bellco Legacy LLC is owned and managed by trusts controlled by the reporting person and Rebecka Belldegrun.

Read SEC document
May 16, 2024 Filed May 20, 2024 22:01 UTC
Chang David DDirector · President and CEO
GrantCommon Stock 344,828 $2.90 $1,000,001.20
Disclosure

SEC source: 0001593968-24-000714 · primary_01.xml · nonDerivative · entry 1

Chang David D · CIK 0001611024 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,810,106

F1 · shares: These shares of common stock were acquired directly from Allogene Therapeutics, Inc (the "Issuer") in a registered direct offering.

Read SEC document
April 22, 2024 Filed Apr 24, 2024 16:18 UTC
MOORE TIMOTHY L.Chief Technical Officer
Tax withholdingCommon Stock 17,360 $3.47 $60,188.86
Disclosure

SEC source: 0001593968-24-000614 · primary_01.xml · nonDerivative · entry 1

MOORE TIMOTHY L. · CIK 0001669207 · Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 265,459

F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.44 to $3.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
March 14, 2024 Filed Mar 19, 2024 00:10 UTC
Chang David DDirector · President and CEO
Tax withholdingCommon Stock 53,393 $4.33 $231,191.69
Disclosure

SEC source: 0001593968-24-000477 · primary_01.xml · nonDerivative · entry 1

Chang David D · CIK 0001611024 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,465,278

F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.29 to $4.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F3 · balance_after: Includes 5,468 shares of the Issuer's common stock acquired by the reporting person on March 15, 2024 pursuant to an employee stock purchase program.

Read SEC document
January 30, 2024 Filed Mar 7, 2024 02:52 UTC
Parker Geoffrey M.CHIEF FINANCIAL OFFICER
PurchaseCommon Stock 190 $3.60 $683.05
Disclosure

SEC source: 0001593968-24-000449 · primary_01.xml · nonDerivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 819,590

F1 · shares: Mr. Parker was notified by his broker on March 4, 2024 that these shares were purchased in an account held by the Geoffrey M. Parker and Jill G. Parker Rev. Trust dated January 27, 2000 for which Mr. Parker does not have discretion. This account is intended to closely track the performance of the Russell 2000 and is frequently rebalanced by an algorithm designed by the broker which led to the purchase of these shares. Restrictions have been now placed on all such accounts held by the Trust to avoid such purchases of the Issuer stock in the future.

Read SEC document
January 25, 2024 Filed Jan 31, 2024 22:45 UTC
Roberts ZacharyEVP of R&D
GrantStock Option (Right to buy) · Derivative 494,949 $0.00 Strike: $3.20 $0.00
Disclosure

SEC source: 0001593968-24-000193 · primary_01.xml · derivative · entry 2

Roberts Zachary · CIK 0001851044 · EVP of R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 494,949

Underlying: Common Stock · 494,949 shares

Expires 2034-01-25

F1 · derivative.exercise_date: 1/3 of the shares subject to the stock option shall vest on January 25, 2025, and the remaining shares shall vest in 24 equal monthly installments thereafter.

Read SEC document
January 25, 2024 Filed Jan 31, 2024 22:45 UTC
Roberts ZacharyEVP of R&D
GrantCommon Stock 140,000 $0.00 $0.00
Disclosure

SEC source: 0001593968-24-000193 · primary_01.xml · nonDerivative · entry 1

Roberts Zachary · CIK 0001851044 · EVP of R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 515,253

Read SEC document
January 25, 2024 Filed Jan 31, 2024 17:51 UTC
MOORE TIMOTHY L.Chief Technical Officer
GrantStock Option (Right to buy) · Derivative 341,515 $0.00 Strike: $3.20 $0.00
Disclosure

SEC source: 0001593968-24-000197 · primary_01.xml · derivative · entry 2

MOORE TIMOTHY L. · CIK 0001669207 · Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 341,515

Underlying: Common Stock · 341,515 shares

Expires 2034-01-25

F1 · derivative.exercise_date: 1/3 of the shares subject to the stock option shall vest on January 25, 2025, and the remaining shares shall vest in 24 equal monthly installments thereafter.

Read SEC document
January 25, 2024 Filed Jan 31, 2024 17:51 UTC
MOORE TIMOTHY L.Chief Technical Officer
GrantCommon Stock 96,600 $0.00 $0.00
Disclosure

SEC source: 0001593968-24-000197 · primary_01.xml · nonDerivative · entry 1

MOORE TIMOTHY L. · CIK 0001669207 · Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 282,819

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.